Semafore Pharmaceuticals raises $9.5 million in financing

Semafore Pharmaceuticals Inc. has raised $9.5 million in equity partly to finance Phase I clinical tests of its cancer treatment.

The start-up Indianapolis drug developer said both existing and new investors were involved in the infusion, and that the funding would be paired with $4 million received last year from the state’s 21st Century Research and Technology Fund, the Cancer Treatment Research Foundation and the Multiple Myeloma Research Foundation.